The most effective treatments for eczema accomplish three things: They calm inflammation, bring relief from itch and restore ...
Investor's Business Daily on MSN
Sanofi Tumbles As New Eczema Drug Lags Dupixent's 'Compelling Bar'
SanofiSNY stock plummeted Thursday after the company's experimental eczema drug proved meaningfully inferior to Dupixent, a blockbuster drug Sanofi codeveloped with Regeneron ...
Asianet Newsable on MSN
Sanofi’s New Experimental Eczema Drug Meets Goals Of Late-stage Trial, But Wall Street Expected More
Amlitelimab, dosed every four weeks or every 12 weeks, demonstrated statistically significant and clinically meaningful efficacy in skin clearance and disease severity compared to placebo at week 24, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback